CRIS
Price
$1.64
Change
-$0.03 (-1.80%)
Updated
Sep 2 closing price
Capitalization
20.5M
VTGN
Price
$3.52
Change
+$0.18 (+5.39%)
Updated
Sep 2 closing price
Capitalization
108M
Interact to see
Advertisement

CRIS vs VTGN

Header iconCRIS vs VTGN Comparison
Open Charts CRIS vs VTGNBanner chart's image
Curis
Price$1.64
Change-$0.03 (-1.80%)
Volume$35.72K
Capitalization20.5M
VistaGen Therapeutics
Price$3.52
Change+$0.18 (+5.39%)
Volume$679.2K
Capitalization108M
CRIS vs VTGN Comparison Chart in %
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. VTGN commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and VTGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CRIS: $1.67 vs. VTGN: $3.34)
Brand notoriety: CRIS and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 13% vs. VTGN: 125%
Market capitalization -- CRIS: $20.5M vs. VTGN: $108M
CRIS [@Biotechnology] is valued at $20.5M. VTGN’s [@Biotechnology] market capitalization is $108M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • CRIS’s TA Score: 4 bullish, 4 bearish.
  • VTGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than VTGN.

Price Growth

CRIS (@Biotechnology) experienced а -2.05% price change this week, while VTGN (@Biotechnology) price change was +5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($108M) has a higher market cap than CRIS($20.5M). VTGN YTD gains are higher at: 19.322 vs. CRIS (-45.425). CRIS has higher annual earnings (EBITDA): -36.02M vs. VTGN (-58.99M). VTGN has more cash in the bank: 63.2M vs. CRIS (10.1M). CRIS (2.31M) and VTGN (2.36M) have identical debt. CRIS has higher revenues than VTGN: CRIS (11.4M) vs VTGN (646K).
CRISVTGNCRIS / VTGN
Capitalization20.5M108M19%
EBITDA-36.02M-58.99M61%
Gain YTD-45.42519.322-235%
P/E RatioN/AN/A-
Revenue11.4M646K1,765%
Total Cash10.1M63.2M16%
Total Debt2.31M2.36M98%
FUNDAMENTALS RATINGS
CRIS vs VTGN: Fundamental Ratings
CRIS
VTGN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9044
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (49) in the Biotechnology industry is in the same range as CRIS (57). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as CRIS (100). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's Price Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for CRIS (90). This means that VTGN’s stock grew somewhat faster than CRIS’s over the last 12 months.

VTGN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRISVTGN
RSI
ODDS (%)
Bullish Trend 5 days ago
71%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
86%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXTT0.440.15
+52.17%
Next Technology Holding
EA171.950.96
+0.56%
Electronic Arts
GES16.81-0.08
-0.47%
Guess
WKHS1.32-0.05
-3.65%
Workhorse Group Inc
CYTK35.33-2.02
-5.41%
Cytokinetics

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with VTGN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
N/A
VTGN - CRIS
38%
Loosely correlated
+3.41%
RAIN - CRIS
38%
Loosely correlated
N/A
CGON - CRIS
37%
Loosely correlated
+0.39%
ROIV - CRIS
36%
Loosely correlated
-0.08%
OBIO - CRIS
35%
Loosely correlated
+0.74%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with COGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+5.39%
COGT - VTGN
41%
Loosely correlated
-0.66%
IPSC - VTGN
39%
Loosely correlated
-3.23%
IMNM - VTGN
39%
Loosely correlated
-2.42%
CRIS - VTGN
38%
Loosely correlated
-1.80%
SRRK - VTGN
38%
Loosely correlated
+1.44%
More